143 related articles for article (PubMed ID: 37916579)
1. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
2. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
[TBL] [Abstract][Full Text] [Related]
3. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
4. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
Kim JM; Lee J; Sung SH
Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
[TBL] [Abstract][Full Text] [Related]
5. Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis.
Jia L; Rood T; Kirkpatrick J; Sarode V
J Am Soc Cytopathol; 2024; 13(2):149-155. PubMed ID: 38341300
[TBL] [Abstract][Full Text] [Related]
6. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
7. Urinary tract cytology showing variant morphology and divergent differentiation.
Arshia A; Hassan FA; Hensley PJ; Allison DB
Cytopathology; 2024 Mar; 35(2):199-212. PubMed ID: 37919868
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Low-Grade Urothelial Neoplasm in the Era of the Second Edition of the Paris System for Reporting Urinary Cytology.
Christofidis K; Moulavasilis N; Fragkiadis E; Goutas D; Lazaris AC; Mitropoulos D; Mikou P
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627884
[TBL] [Abstract][Full Text] [Related]
10. Should "suspicious for high-grade urothelial carcinoma" and "positive for high-grade urothelial carcinoma" remain separate categories?
Nguyen L; Nilforoushan N; Krane JF; Bose S; Bakkar R
Cancer Cytopathol; 2021 Feb; 129(2):156-163. PubMed ID: 33036060
[TBL] [Abstract][Full Text] [Related]
11. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
12. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
[TBL] [Abstract][Full Text] [Related]
13. Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility.
Chen L; He H; Zarka MA; Zhou M; Magi-Galluzzi C
Cytojournal; 2015; 12():17. PubMed ID: 26288652
[TBL] [Abstract][Full Text] [Related]
14. Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.
Bakkar R; Mirocha J; Fan X; Frishberg DP; de Peralta-Venturina M; Zhai J; Bose S
Cytojournal; 2019; 16():21. PubMed ID: 31741668
[TBL] [Abstract][Full Text] [Related]
15. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
16. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
17. Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
Tian W; Shore KT; Shah RB
Cancer Cytopathol; 2021 Feb; 129(2):114-120. PubMed ID: 32931158
[TBL] [Abstract][Full Text] [Related]
18. Utility of The Paris System for Reporting Urinary Cytology in upper urinary tract specimens.
Xing J; Monaco SE; Pantanowitz L
J Am Soc Cytopathol; 2018; 7(6):311-317. PubMed ID: 31043301
[TBL] [Abstract][Full Text] [Related]
19. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
20. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]